What 6 Analyst Ratings Have To Say About MetLife
MetLife (NYSE:MET) has observed the following analyst ratings within the last quarter:
Morgan Stanley Maintains Overweight on MetLife, Raises Price Target to $76
Morgan Stanley maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $75 to $76.
Evercore ISI Group Upgrades MetLife to Outperform, Raises Price Target to $74
Evercore ISI Group analyst Thomas Gallagher upgrades MetLife (NYSE:MET) from In-Line to Outperform and raises the price target from $67 to $74.
Wells Fargo Maintains Overweight on MetLife, Lowers Price Target to $74
Wells Fargo analyst Elyse Greenspan maintains MetLife (NYSE:MET) with a Overweight and lowers the price target from $75 to $74.
Insurance Stocks Moving In Friday’s Intraday Session
According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.
Earnings Scheduled For November 3, 2021
Companies Reporting Before The Bell
• R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.
Here’s How Much You Would Have Made Owning MetLife Stock In The Last 20 Years
MetLife (NYSE:MET) has outperformed the market over the past 90 days by 8.02%, generating a 12.23% return for its investors over the time period. Now, given this information, it may seem like price appreciation alone is the best way to have made money on this stock, that's not actually the case.
Morgan Stanley Maintains Overweight on MetLife, Raises Price Target to $75
Morgan Stanley analyst Nigel Dally maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $74 to $75.